Drug Profile
Research programme: withdrawal therapy - Beech Tree Labs
Alternative Names: BTL-ng; BTL-NGFLatest Information Update: 09 Mar 2021
Price :
$50
*
At a glance
- Originator Beech Tree Labs; University of North Carolina at Chapel Hill
- Class Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anxiety disorders; Major depressive disorder
- No development reported Smoking withdrawal
Most Recent Events
- 09 Mar 2021 Preclinical trials in Anxiety disorders in USA (unspecified route), prior to March 2021 (Beech Tree Labs pipeline, March 2021)
- 09 Mar 2021 Preclinical trials in Major depressive disorder in USA (unspecified route), prior to March 2021 (Beech Tree Labs pipeline, March 2021)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Smoking-withdrawal in USA